Jpmorgan Chase & CO Electromed, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Electromed, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 29,572 shares of ELMD stock, worth $728,654. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,572
Previous 34
86876.47%
Holding current value
$728,654
Previous $1,000
70400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ELMD
# of Institutions
84Shares Held
3.5MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA436KShares$10.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA238KShares$5.87 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny202KShares$4.98 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX189KShares$4.67 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN164KShares$4.03 Million0.25% of portfolio
About Electromed, Inc.
- Ticker ELMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,492,200
- Market Cap $209M
- Description
- Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consist...